4492 — Genetec Income Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro CapContrarian

Annual income statement for Genetec, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	4,079	4,683	5,864	7,148	8,125
Cost of Revenue
Gross Profit	1,562	1,962	2,318	2,909	3,271
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,825	4,631	5,782	6,525	7,452
Operating Profit	254	52.6	82.2	623	672
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	276	117	87.9	630	662
Provision for Income Taxes
Net Income After Taxes	173	56.6	23.8	415	421
Net Income Before Extraordinary Items
Net Income	173	56.6	23.8	415	421
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	173	56.6	23.8	415	421
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	15.3	10.8	6.74	43	45.8
Dividends per Share
Special Dividends per Share